Peri‐implantitis‐like medication‐related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope

Abstract Objective In the recent years, an increasing number of peri‐implant medication‐related osteonecrosis of the jaw (PI‐MRONJ) have been reported in literature, both in oncologic and osteoporotic patients. The aim of this study is to describe 19 cases of patients previously diagnosed as affected by peri‐implantitis, who were treated for PI‐MRONJ, with consideration on clinical and histopathological features. Materials and Methods Patients included were affected by postmenopausal osteoporosis and were administered with different antiresorptive drugs. Due to the presence of clinical and radiological signs of peri‐implantitis not healed after non‐surgical periodontal treatment, they were referred to the Complex Operating Unit of Odontostomatology of the University of Bari. Then, after a drug holiday of at least 3 months and cycles of antibiotics, and after other cycles of periodontal treatment, patients underwent the surgical removal of implant fixtures and surrounding bone. Results Although the previous diagnosis of peri‐implantitis, the histopathological analysis with both conventional and confocal laser scanner microscopy confirmed the diagnosis of peri‐implantitis‐like MRONJ. Conclusion Peri‐implantitis not healed after conventional treatment in patients at risk on MRONJ occurrence should be considered as peri‐implantitis‐like PI‐MRONJ and treated as required in order to get complete healing of the pathological condition, thus avoiding delay in the diagnosis.

[1]  P. Vescovi,et al.  Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 , 2020, International journal of environmental research and public health.

[2]  G. Campisi,et al.  Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib. , 2019, International journal of oral and maxillofacial surgery.

[3]  G. Huynh-Ba,et al.  Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of clinical periodontology.

[4]  G. Huynh-Ba,et al.  Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of clinical periodontology.

[5]  E. Maiorano,et al.  A Case of Osteonecrosis of the Jaw in a Patient with Crohn’s Disease Treated with Infliximab , 2017, The American journal of case reports.

[6]  F. Mazzoni,et al.  Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect. , 2017, Current medicinal chemistry.

[7]  M. Ehrenfeld,et al.  Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis? , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[8]  E. Maiorano,et al.  Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience , 2016, International journal of dentistry.

[9]  A. Polimeni,et al.  Adalimumab: Another Medication Related to Osteonecrosis of the Jaws? , 2016, Case reports in dentistry.

[10]  T. Dodson,et al.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[11]  A. Santarelli,et al.  Osteopontin, osteocalcin and OB-cadherin expression in Synthetic nanohydroxyapatite vs bovine hydroxyapatite cultured Osteoblastic-like cells. , 2014, Journal of biological regulators and homeostatic agents.

[12]  E. Maiorano,et al.  New Dimensional Staging of Bisphosphonate-Related Osteonecrosis of the Jaw Allowing a Guided Surgical Treatment Protocol: Long-Term Follow-Up of 266 Lesions in Neoplastic and Osteoporotic Patients from the University of Bari , 2014, International journal of dentistry.

[13]  So-Young Choi,et al.  Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. , 2014, Clinical oral implants research.

[14]  K. Grätz,et al.  Osteopathology induced by bisphosphonates and dental implants: clinical observations , 2012, Clinical Oral Investigations.

[15]  A. Piattelli,et al.  Osteonecrosis of the posterior mandible after implant insertion: a clinical and histological case report. , 2011, Clinical implant dentistry and related research.

[16]  P. Nocini,et al.  Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  S. Koka,et al.  Survival of dental implants in post-menopausal bisphosphonate users. , 2010, Journal of prosthodontic research.

[18]  N. Yarom,et al.  Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[19]  A. Goss,et al.  The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[20]  E. Maiorano,et al.  Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. , 2009, Bone.

[21]  L. Assael,et al.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[22]  R. E. Bell,et al.  Oral bisphosphonates and dental implants: a retrospective study. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[23]  R. Kraut,et al.  Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[24]  S. Drew,et al.  Osteonecrosis of the Jaws and Bisphosphonate Therapy , 2007, Journal of dental research.

[25]  G. Sándor,et al.  A review of bisphosphonate-associated osteonecrosis of the jaws and its management. , 2007, Journal.

[26]  C. Scully,et al.  Dental Endosseous Implants in Patients on Bisphosphonate Therapy , 2006, Implant dentistry.

[27]  R. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.